Dayan, S., Ogilvie, P., Rivkin, A. Z., Yoelin, S. G., Garcia, J. K., & Ferrusi, I. L. (2017). OnabotulinumtoxinA for Treatment of Moderate-to-Severe Horizontal Lines and Glabellar Lines from the Subject’s Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study. SKIN The Journal of Cutaneous Medicine, 1(3.1), s82. https://doi.org/10.25251/skin.1.supp.81